Inhibition of the JAK2/STAT3 Pathway Reduces Gastric Cancer Growth In Vitro and In Vivo

• Louise M. Judd ,

  Contributed equally to this work with: Louise M. Judd, Treve R. Menheniott

  Affiliation Infection and Immunity Division, Murdoch Children’s Research Institute, Parkville, Victoria, Australia

  ⨯
• Treve R. Menheniott ,

  Contributed equally to this work with: Louise M. Judd, Treve R. Menheniott

  Affiliation Infection and Immunity Division, Murdoch Children’s Research Institute, Parkville, Victoria, Australia

  ⨯
• Hui Ling,

  Affiliation Department of Pathology and Cancer Research Institute, University of South China, Hengyang, Hunan, China

  ⨯
• Cameron B. Jackson,

  Affiliation Infection and Immunity Division, Murdoch Children’s Research Institute, Parkville, Victoria, Australia

  ⨯
• Meegan Howlett,

  Affiliation Infection and Immunity Division, Murdoch Children’s Research Institute, Parkville, Victoria, Australia

  ⨯
• Anastasia Kalantzis,

  Affiliation Infection and Immunity Division, Murdoch Children’s Research Institute, Parkville, Victoria, Australia

  ⨯
• Waldemar Priebe,

  Affiliation Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Andrew S. Giraud

  * E-mail: andrew.giraud@mcri.edu.au

  Affiliation Infection and Immunity Division, Murdoch Children’s Research Institute, Parkville, Victoria, Australia

  ⨯